Fludrocortisone Acetate Tablet
Product Images NDC 70954-252
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Fludrocortisone Acetate (NDC 70954-252). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Novitium Pharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Fludro1 (Fludro1)
This is a description of Fludrocortisone Acetate tablets, a potent drug available in a 30-tablet bulk package from Novitium Pharma LLC. Each tablet contains 0.1 mg of Fludrocortisone Acetate. The recommended dosage is detailed in an accompanying outsert. It should be stored between 20°C and 25°C and not exposed to excess heat. The tablets must be dispensed in an airtight and light-resistant container. It comes with a warning to keep it out of children's reach. Unfortunately, no additional information is available.*
Fludro2 (Fludro2)
This is a medication called Fludrocortisone Acetate in tablet form with a concentration of 0.1 mg per tablet. This is a potent drug, and the dosages should be followed as per the accompanying prescription. The tablets are manufactured by Novitium Pharma LLC and come in a bulk pack. The tablets should be stored at room temperature, and excess heat should be avoided. These should be dispensed in a tightly closed, light-resistant container as required. This medication should be kept out of the reach of children. Manufacturing date of the medication is March 2022.*
Fludro3 (Fludro3)
Fludrocortisone Acetate Tablets by Novitium Pharma is a potent drug used for treating low levels of steroid hormones. Each tablet contains 0.1 mg fludrocortisone acetate, and 500 tablets are contained in each package. The package needs to be stored at 20° to 25°C and dispensed in a child-resistant container to prevent children's access. The USP outsert that accompanies the product should provide complete prescribing information about dosage recommendations.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.